Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Augusta University Research Institute Inc. has 4 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 4 pending office actions are distributed among 4 distinct examiners and 3 distinct art units. This distribution shows that the company's biotech research is being reviewed by a different individual for every pending matter, across 3 distinct art units at the patent office. For a practitioner, this requires managing four unique examiner relationships and three different art unit standards.
The busiest examiner for Augusta University Research Institute Inc. is SKROBARCZYK III, ROBERT ANTHONY, who is currently overseeing 1 busiest examiner pending action. With 4 distinct examiners each handling an action, the workload is spread across the portfolio. No single examiner holds more influence than another over the company's current patent prospects. Success in the Biotechnology & Pharmaceuticals area will depend on the independent outcomes of the 4 pending office actions. Practitioners must tailor their approach to the specific requirements of the 3 distinct art units while addressing the individual preferences of the 4 distinct examiners involved.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §103 only | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SKROBARCZYK III, ROBERT ANTHONY | 1 | 16.7% | +16.3% |
| JAVANMARD, SAHAR | 1 | 64.8% | +34.1% |
| MARCSISIN, ELLEN JEAN | 1 | 34.5% | +49.3% |
| RAMACHANDRAN, UMAMAHESWARI | 1 | 54.6% | +53.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19036891 | METHODS AND SYSTEMS FOR DEEP BRAIN STIMULATION OF THE NUCLEUS BASALIS OF MEYNERT | SKROBARCZYK III, ROBERT ANTHONY | — |
| 18546720 | CANNABIDIOL FOR TREATING NEURODEGENERATIVE DISEASES | JAVANMARD, SAHAR | — |
| 18346483 | SYSTEMS AND REAGENTS FOR DETECTION OF FREE MONOCLONAL IMMUNOGLOBULIN LIGHT CHAINS IN BIOLOGICAL SAMPLES | MARCSISIN, ELLEN JEAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17998790 | CANNABIDIOL AS A THERAPEUTIC MODALITY FOR COVID-19 | RAMACHANDRAN, UMAMAHESWARI | 23d |
| 19036891 | METHODS AND SYSTEMS FOR DEEP BRAIN STIMULATION OF THE NUCLEUS BASALIS OF MEYNERT | SKROBARCZYK III, ROBERT ANTHONY | — |
| 18546720 | CANNABIDIOL FOR TREATING NEURODEGENERATIVE DISEASES | JAVANMARD, SAHAR | — |
| 18346483 | SYSTEMS AND REAGENTS FOR DETECTION OF FREE MONOCLONAL IMMUNOGLOBULIN LIGHT CHAINS IN BIOLOGICAL SAMPLES | MARCSISIN, ELLEN JEAN | — |
| Art Unit | Apps |
|---|---|
| 1622 | 1 |
| 1677 | 1 |
| 1627 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19036891 | METHODS AND SYSTEMS FOR DEEP BRAIN STIMULATION OF THE NUCLEUS BASALIS OF MEYNERT | SKROBARCZYK III, ROBERT ANTHONY | — | §102§103 | Final Rejection | — | Pending | Jan 24, 2025 |
| 18546720 | CANNABIDIOL FOR TREATING NEURODEGENERATIVE DISEASES | JAVANMARD, SAHAR | 1622 | §102§112 | Non-Final OA | — | Pending | Aug 16, 2023 |
| 18346483 | SYSTEMS AND REAGENTS FOR DETECTION OF FREE MONOCLONAL IMMUNOGLOBULIN LIGHT CHAINS IN BIOLOGICAL SAMPLES | MARCSISIN, ELLEN JEAN | 1677 | §101§102§103§112 | Non-Final OA | — | Pending | Jul 03, 2023 |
| 17998790 | CANNABIDIOL AS A THERAPEUTIC MODALITY FOR COVID-19 | RAMACHANDRAN, UMAMAHESWARI | 1627 | §103 | Final Rejection | 23d | Pending | Nov 14, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial